Six participants were found with saliva IgA antibodies to the three SARS-CoV-2 antigens at levels that were consistent with previous infection, but with no history of COVID-19 infection and no evidence for seroconversion, with very low or undetectable serum IgG antibodies to Spike (Fig. 5A) and NP (not shown). This evidence concerns the gene CD79A and infection.